WuXi PharmaTech (WX) Announces Collaboration with Janssen Pharma Division for Preclinical Services

March 2, 2010 7:38 AM EST Send to a Friend
WuXi PharmaTech (Cayman) Inc. (NYSE: WX) today announced it has reached an agreement with Johnson & Johnson Pharmaceutical Research ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login